Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats.
作者信息
Kempf S R, Ivankovic S, Wiessler M, Schmähl D
出版信息
Br J Cancer. 1985 Dec;52(6):937-9. doi: 10.1038/bjc.1985.280.
Abstract
摘要
相似文献
1
Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats.通过给大鼠施用2-巯基乙烷磺酸钠（MESNA）有效预防顺铂（CDDP）的肾毒性。
Br J Cancer. 1985 Dec;52(6):937-9. doi: 10.1038/bjc.1985.280.
2
Nephrotoxicity and carcinogenic risk of cis-platin (CDDP) prevented by sodium 2-mercaptoethane-sulfonate (Mesna): experimental results.2-巯基乙烷磺酸钠（美司钠）预防顺铂（CDDP）的肾毒性和致癌风险：实验结果
Cancer Treat Rev. 1987 Dec;14(3-4):365-72. doi: 10.1016/0305-7372(87)90031-4.
3
Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.顺铂诱导的肾铜流失和肾毒性可通过单剂量二乙氨基二硫代甲酸盐改善，但美司钠不能。
Toxicol Appl Pharmacol. 1992 Feb;112(2):182-9. doi: 10.1016/0041-008x(92)90186-v.
4
[Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].二巯基丁二酸钠预防环磷酰胺和异环磷酰胺的尿路毒性作用（初步报告）（作者译）
Arzneimittelforschung. 1982;32(5):486-7.
5
6
Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).通过额外给予尿路保护剂2-巯基乙烷磺酸钠（美司钠）和2,2'-二硫代双乙烷磺酸钠（二巯基丁二酸钠）预防环磷酰胺治疗大鼠的膀胱肿瘤。
Cancer. 1983 Feb 15;51(4):606-9. doi: 10.1002/1097-0142(19830215)51:4<606::aid-cncr2820510409>3.0.co;2-s.
7
Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.用2-巯基乙烷磺酸钠预防环磷酰胺性膀胱炎：一项组织学研究。
J Urol. 1984 Sep;132(3):580-2. doi: 10.1016/s0022-5347(17)49751-5.
8
Mesna does not reduce cisplatin induced nephrotoxicity in the rat.
Cancer Chemother Pharmacol. 1985;15(3):307-9. doi: 10.1007/BF00263907.
9
The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis.使用2-巯基乙烷磺酸钠预防环磷酰胺所致膀胱炎。
J Urol. 1984 May;131(5):960-2. doi: 10.1016/s0022-5347(17)50729-6.
10
Studies on hemotoxicity of cyclophosphamide, doxorubicin and cis-diamminodichloroplatinum combined with sodium-2-mercaptoethane sulfonate.环磷酰胺、阿霉素和顺二氯二氨铂与2-巯基乙烷磺酸钠联合应用的血液毒性研究
Tumori. 1988 Jun 30;74(3):333-7. doi: 10.1177/030089168807400316.
引用本文的文献
1
Advancing archaeal research through FAIR resource and data sharing, and inclusive community building.通过公平的资源和数据共享以及包容性的社区建设推动古菌研究。
Commun Biol. 2025 Mar 29;8(1):519. doi: 10.1038/s42003-025-07962-8.
2
Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats.化学保护剂BNP7787和美司钠在大鼠静脉推注后的药代动力学行为。
Br J Cancer. 2004 Apr 19;90(8):1654-9. doi: 10.1038/sj.bjc.6601719.
3
Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.顺铂给药后影响人体尸检肾皮质和肾髓质铂浓度的因素。
Cancer Chemother Pharmacol. 1994;34(1):14-22. doi: 10.1007/BF00686106.
4
Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review.顺铂诱导的肾毒性及毒性调节策略：综述
Cancer Chemother Pharmacol. 1994;35(1):1-9. doi: 10.1007/BF00686277.
5
Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin.磷霉素、美司钠和硫代硫酸钠对顺铂毒性及抗肿瘤活性的影响。
J Cancer Res Clin Oncol. 1988;114(5):497-501. doi: 10.1007/BF00391499.
6
Carcinogenic effect of cisplatin (cis-diammine-dichloroplatinum (II), CDDP) in BD IX rats.顺铂（顺二氨二氯铂（II），CDDP）对BD IX大鼠的致癌作用。
J Cancer Res Clin Oncol. 1986;111(2):133-6. doi: 10.1007/BF00400751.
本文引用的文献
1
Acute and chronic cisplatin nephropathy in rats.大鼠急性和慢性顺铂肾病
Lab Invest. 1981 May;44(5):397-402.
2
Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).氮杂磷三环类细胞抑制剂的尿路毒性及其预防研究——III. 2-巯基乙烷磺酸钠（美司钠）的作用概况。
Eur J Cancer Clin Oncol. 1982 Dec;18(12):1377-87. doi: 10.1016/0277-5379(82)90143-2.
3
The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics.美司钠用于抑制环磷酰胺、异环磷酰胺及其他氮杂磷环类细胞抑制剂的尿路毒性副作用的研发。
Recent Results Cancer Res. 1980;74:270-8. doi: 10.1007/978-3-642-81488-4_32.
4
Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity.血浆铂水平：与顺铂剂量及肾毒性的关系。
Cancer Treat Rep. 1983 Feb;67(2):169-72.
5
Minireview. The nephrotoxicity of cisplatin.综述。顺铂的肾毒性。
Life Sci. 1983 Feb 14;32(7):685-90. doi: 10.1016/0024-3205(83)90299-0.
6
High-dose cisplatin in hypertonic saline.高剂量顺铂溶于高渗盐水中。
Ann Intern Med. 1984 Jan;100(1):19-24. doi: 10.7326/0003-4819-100-1-19.
7
Platinum compounds: a new class of potent antitumour agents.铂化合物：一类新型强效抗肿瘤药物。
Nature. 1969 Apr 26;222(5191):385-6. doi: 10.1038/222385a0.
8
Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.
Cancer Chemother Rep. 1971 Feb;55(1):1-8.
9
High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.高剂量顺铂二氯二氨络铂：通过甘露醇利尿改善肾毒性。
Cancer. 1977 Apr;39(4):1372-81. doi: 10.1002/1097-0142(197704)39:4<1372::aid-cncr2820390404>3.0.co;2-j.
10
The renal pathology in clinical trials of cis-platinum (II) diamminedichloride.
Cancer. 1977 Apr;39(4):1362-71. doi: 10.1002/1097-0142(197704)39:4<1362::aid-cncr2820390403>3.0.co;2-n.
Zotero 插件